Pfizer (PFE)
(Delayed Data from NYSE)
$23.49 USD
+0.20 (0.86%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $23.52 +0.03 (0.13%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Pfizer Inc. has a market cap of $132.41B, which represents its share price of $23.29 multiplied by its outstanding shares number of 5.69B. As a large-cap company, PFE's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PFE 23.49 +0.20(0.86%)
Will PFE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PFE
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pfizer (PFE) Dips More Than Broader Market: What You Should Know
Microsoft Q4 Earnings & Revenues Beat on Cloud Business Expansion
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
Other News for PFE
Walt Disney, McDonald's, Palantir Set To Report Earnings
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)
Bristol-Myers Q2 Earnings Review: Solid Quarter, But Incoming CMO Must Fix Pipeline
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Experts helping vaccine advisors are reportedly ousted at CDC